NCT07152431View on ClinicalTrials.gov

Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2028

Conditions

Crohn Disease

Trial Locations (1)

Unknown

RECRUITING

NHS Lothian, Edinburgh

All Listed Sponsors

lead

University of Edinburgh

OTHER